Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Nov 2000

Rebbeck T R

Abstract excerpt

The availability of genetic testing for inherited mutations in the BRCA1 and BRCA2 genes provides potentially valuable information to women at elevated risk of breast or ovarian cancer. Unfortunately, women who have inherited a mutation in BRCA1 or BRCA2 have relatively few clinical management options available to reduce their risk of developing breast or ovarian cancer. Because most options for ovarian cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Heterozygote

Share to Neoplasm Proteins

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 11060335

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.PMID 11060335Read ↗

Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.Semantic proximity Read ↗

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.Semantic proximity Read ↗

High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.Semantic proximity Read ↗

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.Semantic proximity Read ↗

Genetic susceptibility testing and prophylactic oophorectomy.Semantic proximity Read ↗

Prophylactic oophorectomy in women at increased cancer risk.Semantic proximity Read ↗

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.Semantic proximity Read ↗

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence.Semantic proximity Read ↗

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.